+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 130Years
All Genders
ID05417594

Open-label Study to Assess Safety and Effects of AZD9574 Alone and With Other Cancer Drugs in Advanced Solid Tumors

Led by AstraZeneca · Updated on 2026-10-05

695

Participants Needed

32

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating AZD9574, both alone and combined with other anti-cancer drugs, in people with advanced solid tumors that have returned or worsened. This modular phase IIIa study aims to assess the safety, tolerability, how the drug moves and acts in the body, and preliminary effectiveness. The study includes participants with various advanced cancers, including ovarian, breast, pancreatic, prostate, and glioma, among others, with specific genetic mutations related to DNA repair. Participants will receive AZD9574 alone or with other treatments like temozolomide, trastuzumab deruxtecan, or datopotamab deruxtecan, depending on their cancer type and study module. The study has several parts, including dose escalation and expansion phases, with some participants receiving oral AZD9574 and others receiving combinations with intravenous drugs. Some modules include additional imaging studies and biomarker testing to evaluate drug effects. During the study, participants will undergo regular assessments including scans, blood tests, heart monitoring, and evaluations of cancer response and side effects. Researchers will track adverse events, lab changes, and performance status from first dose through about three years post-treatment. The study also monitors how the drug is processed in the body and its effects on tumors over time. Participation length varies depending on study module and response, with ongoing safety follow-up after treatment ends.

CONDITIONS

Brief Title

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Team

A

AstraZeneca Clinical Study Information Center

A

AstraZeneca Breast Cancer Study Locator Service

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here